Evaluation of molecular markers for immunological activities and immune cell quantitation parameters to predict outcome and treatment effects in chemo-endocrine treated breast cancer patients treated with or without a taxane
Laufzeit: 01.01.2022 - 31.12.2029
imported
Kurzfassung
Evaluation of molecular markers for immunological activities and immune cell quantitation parameters to predict outcome and treatment effects in chemo-endocrine treated breast cancer patients treated with or without a taxane
